Literature DB >> 9365387

Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I.

F S Apple1, A Falahati, P R Paulsen, E A Miller, S W Sharkey.   

Abstract

This study compared the diagnostic accuracy of the measurement of serum cardiac troponin I (cTnI) with creatine kinase (CK) MB mass in patients with minor myocardial injury whose measured total CK activity did not exceed twice the upper reference limit (300 U/L for men; 200 U/L for women). Forty-eight consecutive patients presenting with chest pain and with in-hospital documentation of myocardial injury were enrolled. Electrocardiogram, echocardiogram, and serial serum CK-MB mass, cTnI, and total CK were measured over 36 h after admission. Peak total CK activity was within normal limits in 28 patients (58%). The mean (+/- SD) peak CK-MB mass and cTnI concentrations were: 16.4 (11.8) micrograms/L and 132 (13.0) micrograms/L; respectively. The peak biochemical marker index (defined as CK-MB or cTnI divided by its respective upper reference limit) was significantly (P < 0.05) higher for cTnI than for CK-MB from 7 to 36 h. The clinical sensitivity for detection of myocardial injury for cTnI was 100% [95% confidence interval (CI): 87.2% to 100%], compared with 81.8% (CI: 67.3% to 91.8%) for CK-MB. Thus, cTnI was more sensitive than CK-MB mass for detection of myocardial injury in patients with small increases of total CK.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365387

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Was it a heart attack? Troponin measurement is not straightforward.

Authors:  Eric S Kilpatrick
Journal:  BMJ       Date:  2002-05-18

2.  What tests for suspected myocardial infarction? Serum cardiac troponin I or creatine kinase?

Authors:  A AlKhenizan; M F Evans
Journal:  Can Fam Physician       Date:  2000-08       Impact factor: 3.275

3.  The role of cardiac troponin I in determining the necessity for exercise electrocardiography in low risk patients with chest pain.

Authors:  S M Fleming; M Divilly; P I Chakravarthi; H Grimes; K Daly
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

4.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

5.  Lack of association between cardiac troponin T and D-dimer in the evaluation of myocardial damage.

Authors:  Rafael Noal Moresco; Luís Cláudio Rosa Vargas; Ronald Halla Júnior; Lúcia Mariano da Rocha Silla
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

6.  A randomized comparison between three types of irrigating fluids during transurethral resection in benign prostatic hyperplasia.

Authors:  Ayman A Yousef; Ghada A Suliman; Osama M Elashry; Mahmoud D Elsharaby; Abd El-Naser K Elgamasy
Journal:  BMC Anesthesiol       Date:  2010-05-28       Impact factor: 2.217

7.  The one year incidence of postoperative myocardial infarction in an orthopedic population.

Authors:  M K Urban; K Jules-Elysee; C Loughlin; W Kelsey; E Flynn
Journal:  HSS J       Date:  2007-12-11

8.  Origanum majorana L. Extract Protects Against Isoproterenol-Induced Cardiotoxicity in Rats.

Authors:  Abeer M Rababa'h; Miya A Alzoubi
Journal:  Cardiovasc Toxicol       Date:  2021-03-30       Impact factor: 3.231

9.  Trends in cardiac biomarker testing in China for patients with acute myocardial infarction, 2001 to 2011: China PEACE-retrospective AMI study.

Authors:  Lijuan Zhan; Frederick A Masoudi; Xi Li; Shuang Hu; Arjun K Venkatesh; John A Spertus; Zhenqiu Lin; Nihar R Desai; Jing Li; Harlan M Krumholz; Lixin Jiang
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

10.  Myocardial injury after aortoiliac revascularization for extensive disease: A survival analysis.

Authors:  Juliana Pereira-Macedo; Neuza Machado; António Pereira-Neves; Vítor Ferreira; José Oliveira-Pinto; Marina Dias-Neto; João Rocha-Neves; José Teixeira; José Andrade
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-07-28       Impact factor: 0.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.